학술논문

Phase I Study of SYNB1891, an Engineered E. coli Nissle Strain Expressing STING Agonist, with and without Atezolizumab in Advanced Malignancies
Document Type
Journal
Source
CLINICAL CANCER RESEARCH; JUL 1 2023, 29 13, p2435-p2444, 10p.
Subject
Language
English
ISSN
15573265